Resonance Health Limited hereby discloses the initial director's interest notice for Michael Sistenich, appointed on 28th April 2026. As per the listing rule 3.19.A.1, Michael Sistenich holds nil securities as a registered holder and nil securities as a non-registered holder. There are no interests in contracts to report at this time.

For further details or inquiries regarding this disclosure, we encourage investors to reach out to our investor relations department. Thank you for your continued interest and support in Resonance Health Limited.